Steering Committee
Miguel Garcia (Technophage)
-
CEO of LxBio Pharmaceuticals and TechnoPhage
-
Board member at VectorB2B
-
Professor at the Egas Moniz Instituto Universitário
-
PharmD, Faculty of Pharmacy, University of Lisbon
-
PhD, Faculty of Pharmacy, University of Lisbon
-
MBA, Catholic University of Portugal
Jorge Brandão (LxBio)
-
Board member at LxBio Pharmaceuticals
-
Board member at SEAPOWER - Associação para o desenvolvimento da economia do mar
-
Manager at IBV - Innovation Bioventures, Lda
-
PADIS - Gestão de Unidades de Saúde, AESE Business School
Rui Rodrigues (VectorB2B)
-
Board member at VectorB2B
-
Board member at DÁVI
-
Founder of Lusomedicamenta (Recipharm)
-
Senior manager in multinational pharmaceutical companies (Janssen Pharmaceuticals)
-
PharmD, Faculty of Pharmacy, University of Lisbon
João Gonçalves (FFUL)
-
Board member at VectorB2B
-
Coordinator of iMed - Research Institute for Medicines
-
Director of the Department of Pharmacy, Pharmacology and Health Technologies at the Faculty of Pharmacy, University of Lisbon
-
PharmD, Faculty of Pharmacy, University of Lisbon
-
PhD, Faculty of Pharmacy, University of Lisbon
Innovation. Dedication. Expertise.
This committee will assume the following functions in the mobilizing agenda:
​
-
Approve the program of activities prepared for the agenda;
​
-
Ensure the alignment of the activities objectives with those of the «Mobilizing Agenda for Business Innovation» and with the strategic objectives of each of the partner members;
​
-
Ensure compliance with the program's contractual obligations towards the Financing Entity;
​
-
Oversee project progress;
​
-
Approve and execute proposed amendment requests to the investment contract;
​
-
Guide actions to solve problems and responses to the risks involved arising from the project;
​
-
Promote the dissemination and sharing of results;
​
-
Analyse and approve the technical-scientific Progress Reports;
​
-
Report project performance to the financing entity.